一个模块化纳米颗粒显示策略为疹病毒gE基于授权的蛋白质支架
Wenhui Xue1,2, Hong Wang1,2, Yarong Zeng1,2
1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China.
PLoS pathogens
|March 2, 2026
概括
一种新型纳米疫苗,Nano-gEVZV,在纳米粒子支架上显示VZV gE,在小鼠模型中显示与Shingrix相比,免疫反应得到改善. 这为带状疹预防提供了一种补充方法.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 纳米技术 纳米技术
背景情况:
- 疹病毒 (Varicella-zoster virus,简称VZV) 导致带状疹,这是一个严重的健康问题,特别是在老年人群中.
- 重组疫苗 (Shingrix, RZV) 的效果很高,但需要替代平台来改善抗原设计和免疫表现.
- 纳米粒子技术允许反复显示抗原,增强免疫反应.
研究的目的:
- 开发和评估一种基于纳米粒子的新型疫苗 (纳米-gEVZV) 显示VZV糖蛋白E (gE) 以预防带状疹.
- 在临床前模型中比较Nano-gEVZV与许可的Shingrix疫苗的免疫性和疗效.
- 探索纳米粒子平台,以提高VZV抗原的可制造性和免疫呈现.
主要方法:
- 开发了Nano-gEVZV,使用乙肝E疫苗抗原支架和纳米粘合剂来重复显示VZV gE.
- 评估了抗原呈现细胞 (APC) 的抗原吸收和淋巴结保留.
- 在小鼠模型中评估了B细胞和T细胞的反应.
主要成果:
- 与Shingrix相比,Nano-gEVZV显示了APCs增强的抗原吸收和改善的淋巴结保留.
- 在临床前研究中,纳米疫苗诱导了更强的B细胞和T细胞反应.
- 结果表明,基于纳米粒子的平台对VZV抗原显示具有前途.
结论:
- 纳米-gEVZV代表了一种基于纳米粒子的新型疫苗方法,用于VZV,在临床前模型中显示出增强的免疫性.
- 与现有的子单位疫苗相比,这个平台在制造性和免疫表现方面提供了潜在的优势.
- 对以纳米粒子为基础的疫苗的进一步研究可以补充目前预防疹病毒的策略.
相关概念视频
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


